MicroRNA29-a as Diabetic Nephropathy Biomarker in Diabetic Patients (Type 2)
Last updated: 01 Jan 2025
10.21608/mjcu.2019.54875
Diabetes mellitus type 2 – Diabetic nephropathy – Circulating microRNA – Biomarker
MOHAMED Y. NASR, M.D.;
SALWA E. MOHAMED, M.D.
AHMED M. HASSANAIN, M.D.;
RANDA A. GHANOUM, M.D.
SABAH F.
EL-ABED, M.D.
The Department of Molecular Biology, Genetic Engineering & Biotechnology Institut, Sadaat City University* and Laboratory Department, National Heart Institute, General Organization of Hospitals & Teaching Institutes, Ministry of Healthy
87
June
8164
2019-06-01
2018-10-23
2019-06-10
2,593
2,597
0045-3803
2536-9806
https://mjcu.journals.ekb.eg/article_54875.html
https://mjcu.journals.ekb.eg/service?article_code=54875
142
Original Article
263
Journal
The Medical Journal of Cairo University
https://mjcu.journals.ekb.eg/
MicroRNA29-a as Diabetic Nephropathy Biomarker in Diabetic Patients (Type 2)
Details
Type
Article
Created At
22 Jan 2023